Received Sep 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
back and joint pains; back and joint pains; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of back pain in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. In MAY-2025, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced back pain (Verbatim: back and joint pains) and joint pain (Verbatim: back and joint pains). The outcome of the back pain and joint pain were resolved (duration 2 weeks). It was unknown if the reporter considered the back pain and joint pain to be related to RSV vaccine. It was unknown if the company considered the back pain and joint pain to be related to RSV vaccine. Additional Information: GSK Receipt Date: 19-AUG-2025 This case was reported by a patient via interactive digital media. The patient had this respiratory syncytial virus vaccine shot and had back and joint pains for almost 2 weeks afterwards.